Koers Kazia Therapeutics Australian S.E.
Aandelen
KZA
AU000000KZA9
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 10K 6,53K 6,09K | Omzet 2023 | 555 362,56 337,86 | Marktkapitalisatie | 39,72 mln. 25,95 mln. 24,18 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -24 mln. -15,68 mln. -14,61 mln. | Nettowinst (verlies) 2023 | -20 mln. -13,07 mln. -12,18 mln. | EV/omzet 2022 | 7.714 x |
Nettoliquiditeiten 2022 | 7,36 mln. 4,81 mln. 4,48 mln. | Nettoliquiditeiten 2023 | 3,44 mln. 2,25 mln. 2,1 mln. | EV/omzet 2023 | 65.355 x |
K/w-verhouding 2022 |
-3,27
x | K/w-verhouding 2023 |
-1,55
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 45,6% |
Recentste transcriptie over Kazia Therapeutics
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,12% | 42,59 mld. | |
+6,77% | 40,65 mld. | |
+47,36% | 40,57 mld. | |
-11,96% | 26,77 mld. | |
+6,01% | 24,81 mld. | |
-24,92% | 18,17 mld. | |
-3,63% | 11,7 mld. | |
+27,16% | 12,05 mld. | |
+7,30% | 11,1 mld. |